查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2005198

印度细胞检测市场：按产品、检测类型、技术、应用和最终用户划分－产业趋势和预测（至2035年）

India Cell Based Assay Market - Distribution by Products, Type of Assay, Technology, Application and End-user: Industry Trends and Global Forecasts, till 2035
出版日期: | 出版商: Roots Analysis | 英文 120+ Pages | 商品交期: 7-10个工作天内

价格
简介目录

印度细胞检测市场概览

根据 Roots Analysis 的研究，预计到 2035 年，印度基于细胞的检测市场规模将以 9.0% 的复合年增长率增长，从目前的 5.4 亿美元增长到 2035 年的 11.72 亿美元。

印度细胞检测市场-IMG1

印度细胞检测市场：成长与趋势

基于细胞的检测技术是一种体外技术，它利用活细胞来评估药物的疗效、毒性、ADME（吸收、分布、代谢和排泄）特性以及生物机制。这些技术为传统的生化和动物实验提供了更符合生理实际的替代方案。这些检测技术对于临床前试验的安全性评估至关重要，并且还可以证明细胞产品的生物活性和效力。印度的基于细胞的检测市场是生命科学和生物製药行业中一个快速成长的领域。药物研发活动的增加、高通量筛检的自动化以及外包给合约研究组织（CRO）的做法正在加速市场成长。此外，政府和私人对生命科学基础设施的投资也进一步促进了学术界和工业界对此技术的应用。

印度细胞检测市场的新趋势包括采用3D细胞培养模型、类器官、高内涵成像、无标定技术以及与人工智慧/机器学习相结合的资料分析技术。此外，干细胞研究、肿瘤筛检、再生医学和生物相似药开发等领域也涌现新的机会。印度庞大的病患群体和成本优势也是吸引全球临床/临床前外包的重要因素。

成长驱动因素：市场扩张的策略推动者

印度细胞检测市场的主要驱动力来自政府的大力扶持以及对生命科学和生物製药领域研发的大量投入。在生物技术部 (DBT) 和生物技术产业研究援助委员会 (BIRAC) 的主导下，印度政府透过一系列计画提供专款和津贴，并建立专门的生物技术园区。这些措施简化了资金流向，减少了行政障碍，并积极推广动物试验的替代方案。这些措施正在建构一个支持生物製药创新、促进官民合作关係并加速将细胞检测技术整合到药物发现、毒性评估和个人化医疗等临床前工作流程的生态系统。因此，国内外企业正越来越多地利用这些检测技术来支持生物相似药的开发和慢性病研究。尤其是在肿瘤学领域，印度庞大的患者群体为进行生理相关性检测提供了独特的机会。

印度细胞检测市场：主要细分市场

产品类型

  • 消耗品
  • 装置
  • 软体

检测类型

  • 细胞活力
  • 细胞增殖
  • 细胞毒性
  • 细胞死亡
  • 其他的

透过技术

  • 高通量筛检
  • 高内涵筛检
  • 流式细胞技术
  • 无标定检测

目的

  • 药物发现
  • 研究
  • ADME/毒理学测试
  • 其他的

最终用户

  • 製药和生物技术公司
  • CRO
  • 学术和研究机构
  • 政府机构

本报告考察了印度基于细胞的检测市场，提供了概述、背景、市场影响因素分析、市场规模趋势和预测、按各个细分市场进行的详细分析、竞争格局以及主要企业的概况。

目录

第一章：序言

第二章：调查方法

第三章 市场动态

第四章 宏观经济指标

第五章执行摘要

第六章：引言

第七章 市场状况

第八章 公司概况：印度细胞检测市场

  • 章节概要
  • Agilent Technologies
  • Becton, Dickinson and Company（BD）
  • Bio-Rad Laboratories
  • Charles River Laboratories
  • Corning
  • Danaher
  • Lonza
  • Merck KGaA
  • PerkinElmer
  • Promega
  • Revvity
  • Roche
  • Thermo Fisher Scientific

第九章 专利分析

第十章：津贴分析

第十一章 市场影响分析

第十二章：印度细胞检测市场

第十三章：印度细胞检测市场：依产品类型划分

第十四章：印度细胞检测市场：依检测类型划分

第十五章：印度细胞检测市场：依技术划分

第十六章：印度细胞检测市场：依应用划分

第十七章：印度细胞检测市场：依最终用户划分

第十八章 结论

第十九章附录一：表格形式数据

第20章 附录二：公司和组织列表

简介目录
Product Code: RAD00019

India Cell based Assay Market: Overview

As per Roots Analysis, the India cell-based assay market is estimated to grow from USD 540 million in the current year to USD 1,172 million by 2035 at a CAGR of 9.0% during the forecast period, till 2035.

India Cell Based Assay Market - IMG1

India Cell based Assay Market: Growth and Trends

Cell-based assays are in-vitro techniques that use living cells to evaluate drug efficacy, toxicity, ADME (absorption, distribution, metabolism, excretion) properties, and biological mechanisms. These techniques serve as a more physiologically relevant alternative to traditional biochemical or animal-based testing. These assays are essential for assessing safety in preclinical studies and can additionally indicate the biological activity or potency of the cellular product. The India cell-based assay market is a rapidly expanding segment of the life sciences and biopharmaceutical industry. The rise in drug discovery activities, automation in high-throughput screening, and outsourcing operations to CROs have accelerated the expansion of the market. Further, government and private investments in life sciences infrastructure further boost adoption in academic and commercial settings.

Emerging trends in the India cell based assay market include adoption of 3D cell culture models, organoids, high-content imaging, label-free technologies, and integration with AI / ML for data analysis. Further, opportunities lie in stem cell research, oncology screening, regenerative medicine, and expanding biosimilar development. It is worth highlighting that India's large patient population and cost advantages make it attractive for global clinical / preclinical outsourcing.

Growth Drivers: Strategic Enablers of Market Expansion

The India cell-based assay market is primarily driven by robust government initiatives and substantial investments in research and development within the life sciences and biopharmaceutical sectors. Through programs led by the Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC), the country offers targeted subsidies, grants, and the establishment of dedicated biotech parks that streamline funding flows, reduce administrative hurdles, and actively promote alternatives to animal testing. These measures have created a supportive ecosystem for biopharma innovation, encouraging public-private partnerships and accelerating the integration of cell-based assays into preclinical workflows for drug discovery, toxicity evaluation, and personalized medicine applications. As a result, domestic and multinational players are increasingly leveraging these assays to support biosimilar development and chronic disease research, particularly in oncology, where India's large patient population provides unique opportunities for physiologically relevant testing.

Market Challenges: Critical Barriers Impeding Progress

Despite strong growth potential, the India cell-based assay market encounters notable challenges that can hinder broader adoption and scalability. A primary restraint is the elevated cost of advanced instruments, reagents, and end-user licensing agreements, which often make high-throughput screening technologies prohibitively expensive for smaller academic labs and resource-limited organizations. These financial barriers are compounded by the technical complexities involved in assay design, optimizing culture conditions, and measuring precise endpoints which require meticulous standardization to replicate real cellular environments accurately. Variability in outcomes can lengthen operating timeframes and hinder validation processes in the absence of consistent protocols, especially in a market where infrastructure is still developing. Additionally, a shortage of highly skilled professionals trained in advanced cell-based techniques poses a significant hurdle, as the rapid evolution of technologies demands continuous workforce upskilling amid India's competitive talent landscape.

Consumables: Leading Market Segment

In terms of types of products, the market is divided into consumables, instruments and software. At present, consumables capture the majority of the market share. This can be attributed to the fact that laboratories must continuously repurchase reagents, assay kits, microplates, cell lines, probes, labels, and media for every experiment, unlike one-time instrument purchases. This creates a steady demand cycle driven by widespread use in drug discovery, toxicity testing, and high-throughput screening across India's growing pharmaceutical, biotechnology, and CRO sectors.

Cell Viability: Dominating Market Segment

In terms of type of assay, the market is segmented into cell viability, cell proliferation, cytotoxicity, cell death and others. Our projection indicates that cell viability currently holds the largest share of the India cell-based assay market. This dominance stems from its widespread use in drug discovery, toxicity testing, and basic research which are core to India's expanding pharma / biotech and CRO activities.

India Cell based Assay Market: Key Segments

Type of Product

  • Consumables
  • Instruments
  • Software

By Type of Assay

  • Cell Viability
  • Cell Proliferation
  • Cytotoxicity
  • Cell Death
  • Others

By Technology

  • High-Throughput Screening
  • High-Content Screening
  • Flow Cytometry
  • Label-Free Detection

Application

  • Drug Discovery
  • Research
  • ADME / Toxicity Studies
  • Others

End-User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic / Research Institutions
  • Government Organizations

Example Players in India Cell Based Assay Market

  • Agilent Technologies
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories
  • Charles River Laboratories International
  • Corning
  • Danaher Corporation (including subsidiaries like Beckman Coulter)
  • Lonza
  • Merck
  • PerkinElmer
  • Promega
  • Revvity
  • Roche
  • Thermo Fisher Scientific

Key Questions Answered in this Report

  • How many India cell-based assay developers are currently engaged in this market?
  • Which are the leading companies in this market?
  • Which country dominates the India cell-based assay market?
  • What are the key trends observed in the India cell-based assay market?
  • What factors are likely to influence the evolution of this market?
  • What are the primary challenges faced by India cell-based assay developers?
  • What is the current and future India cell-based assay market size?
  • What is the CAGR of India cell-based assay market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
  • The report can aid businesses in identifying future opportunities in any sector. It also helps in understanding if those opportunities are worth pursuing.
  • The report helps in identifying customer demand by understanding the needs, preferences, and behavior of the target audience in order to tailor products or services effectively.
  • The report equips new entrants with requisite information regarding a particular market to help them build successful business strategies.
  • The report allows for more effective communication with the audience and in building strong business relations.

Complementary Benefits

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Market Share Insights
  • 1.3. Key Market Insights
  • 1.4. Report Coverage
  • 1.5. Key Questions Answered
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
    • 2.2.1. Market Landscape and Market Trends
    • 2.2.2. Market Forecast and Opportunity Analysis
    • 2.2.3. Comparative Analysis
  • 2.3. Database Building
    • 2.3.1. Data Collection
    • 2.3.2. Data Validation
    • 2.3.3. Data Analysis
  • 2.4. Project Methodology
    • 2.4.1. Secondary Research
      • 2.4.1.1. Annual Reports
      • 2.4.1.2. Academic Research Papers
      • 2.4.1.3. Company Websites
      • 2.4.1.4. Investor Presentations
      • 2.4.1.5. Regulatory Filings
      • 2.4.1.6. White Papers
      • 2.4.1.7. Industry Publications
      • 2.4.1.8. Conferences and Seminars
      • 2.4.1.9. Government Portals
      • 2.4.1.10. Media and Press Releases
      • 2.4.1.11. Newsletters
      • 2.4.1.12. Industry Databases
      • 2.4.1.13. Roots Proprietary Databases
      • 2.4.1.14. Paid Databases and Sources
      • 2.4.1.15. Social Media Portals
      • 2.4.1.16. Other Secondary Sources
    • 2.4.2. Primary Research
      • 2.4.2.1. Types of Primary Research
        • 2.4.2.1.1. Qualitative Research
        • 2.4.2.1.2. Quantitative Research
        • 2.4.2.1.3. Hybrid Approach
      • 2.4.2.2. Advantages of Primary Research
      • 2.4.2.3. Techniques for Primary Research
        • 2.4.2.3.1. Interviews
        • 2.4.2.3.2. Surveys
        • 2.4.2.3.3. Focus Groups
        • 2.4.2.3.4. Observational Research
        • 2.4.2.3.5. Social Media Interactions
      • 2.4.2.4. Key Opinion Leaders Considered in Primary Research
        • 2.4.2.4.1. Company Executives (CXOs)
        • 2.4.2.4.2. Board of Directors
        • 2.4.2.4.3. Company Presidents and Vice Presidents
        • 2.4.2.4.4. Research and Development Heads
        • 2.4.2.4.5. Technical Experts
        • 2.4.2.4.6. Subject Matter Experts
        • 2.4.2.4.7. Scientists
        • 2.4.2.4.8. Doctors and Other Healthcare Providers
      • 2.4.2.5. Ethics and Integrity
        • 2.4.2.5.1. Research Ethics
        • 2.4.2.5.2. Data Integrity
    • 2.4.3. Analytical Tools and Databases
  • 2.5. Robust Quality Control

3. MARKET DYNAMICS

  • 3.1. Chapter Overview
  • 3.2. Forecast Methodology
    • 3.2.1. Top-down Approach
    • 3.2.2. Bottom-up Approach
    • 3.2.3. Hybrid Approach
  • 3.3. Market Assessment Framework
    • 3.3.1. Total Addressable Market (TAM)
    • 3.3.2. Serviceable Addressable Market (SAM)
    • 3.3.3. Serviceable Obtainable Market (SOM)
    • 3.3.4. Currently Acquired Market (CAM)
  • 3.4. Forecasting Tools and Techniques
    • 3.4.1. Qualitative Forecasting
    • 3.4.2. Correlation
    • 3.4.3. Regression
    • 3.4.4. Extrapolation
    • 3.4.5. Convergence
    • 3.4.6. Sensitivity Analysis
    • 3.4.7. Scenario Planning
    • 3.4.8. Data Visualization
    • 3.4.9. Time Series Analysis
    • 3.4.10. Forecast Error Analysis
  • 3.5. Key Considerations
    • 3.5.1. Demographics
    • 3.5.2. Government Regulations
    • 3.5.3. Reimbursement Scenarios
    • 3.5.4. Market Access
    • 3.5.5. Supply Chain
    • 3.5.6. Industry Consolidation
    • 3.5.7. Pandemic / Unforeseen Disruptions Impact
  • 3.6. Limitations

4. MACRO-ECONOMIC INDICATORS

  • 4.1. Chapter Overview
  • 4.2. Market Dynamics
    • 4.2.1. Time Period
      • 4.2.1.1. Historical Trends
      • 4.2.1.2. Current and Forecasted Estimates
    • 4.2.2. Currency Coverage
      • 4.2.2.1. Major Currencies Affecting the Market
      • 4.2.2.2. Factors Affecting Currency Fluctuations on the Industry
      • 4.2.2.3. Impact of Currency Fluctuations on the Industry
    • 4.2.3. Foreign Currency Exchange Rate
      • 4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
      • 4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
    • 4.2.4. Recession
      • 4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
      • 4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
    • 4.2.5. Inflation
      • 4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 4.2.5.2. Potential Impact of Inflation on the Market Evolution
    • 4.2.6. Interest Rates
      • 4.2.6.1. Interest Rates and Their Impact on the Market
      • 4.2.6.2. Strategies for Managing Interest Rate Risk
    • 4.2.7. Commodity Flow Analysis
      • 4.2.7.1. Type of Commodity
      • 4.2.7.2. Origins and Destinations
      • 4.2.7.3. Value and Weights
      • 4.2.7.4. Modes of Transportation
    • 4.2.8. Global Trade Dynamics
      • 4.2.8.1. Import Scenario
      • 4.2.8.2. Export Scenario
      • 4.2.8.3. Trade Policies
      • 4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
      • 4.2.8.5. Impact of Trade Barriers on the Market
    • 4.2.9. War Impact Analysis
      • 4.2.9.1. Russian-Ukraine War
      • 4.2.9.2. Israel-Hamas War
    • 4.2.10. COVID Impact / Related Factors
      • 4.2.10.1. Global Economic Impact
      • 4.2.10.2. Industry-specific Impact
      • 4.2.10.3. Government Response and Stimulus Measures
      • 4.2.10.4. Future Outlook and Adaptation Strategies
    • 4.2.11. Other Indicators
      • 4.2.11.1. Fiscal Policy
      • 4.2.11.2. Consumer Spending
      • 4.2.11.3. Gross Domestic Product (GDP)
      • 4.2.11.4. Employment
      • 4.2.11.5. Taxes
      • 4.2.11.6. Stock Market Performance
      • 4.2.11.7. Cross-Border Dynamics
  • 4.3. Conclusion

5. EXECUTIVE SUMMARY

6. INTRODUCTION

  • 6.1. Chapter Overview
  • 6.2. Overview of Cell based Assay
    • 6.2.1. Key Characteristics of Cell based Assay
    • 6.2.2. Benefits of Cell based Assay
    • 6.2.3. Disadvantages of Cell based Assay
  • 6.3. Future Perspective

7. MARKET LANDSCAPE

  • 7.1. Chapter Overview
  • 7.2. Cell based Assay: Overall Developers Landscape
    • 7.2.1. Analysis by Year of Establishment
    • 7.2.2. Analysis by Company Size
    • 7.2.3. Analysis by Location of Headquarters
    • 7.2.4. Cell based Assay: Overall Market Landscape
      • 7.2.4.1. Analysis by Products
      • 7.2.4.2. Analysis by Type of Assay
      • 7.2.4.3. Analysis by Technology
      • 7.2.4.3. Analysis by Application

8. COMPANY PROFILES: INDIA CELL-BASED ASSAY MARKET

  • 8.1. Chapter Overview
  • 8.2. Agilent Technologies
    • 8.2.1. Company Overview
    • 8.2.2. Product Portfolio
    • 8.2.3. Financial Information
    • 8.2.4. Recent Developments and Future Outlook
  • 8.3. Becton, Dickinson and Company (BD)
  • 8.4. Bio-Rad Laboratories
  • 8.5. Charles River Laboratories
  • 8.6. Corning
  • 8.7. Danaher
  • 8.8. Lonza
  • 8.9. Merck KGaA
  • 8.10. PerkinElmer
  • 8.11. Promega
  • 8.12. Revvity
  • 8.13. Roche
  • 8.14. Thermo Fisher Scientific

9. PATENT ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Scope and Methodology
  • 9.3. Cell-based Assay: Patent Analysis
    • 9.3.1. Analysis by Patent Publication Year
    • 9.3.2. Analysis by Type of Patent and Patent Publication Year
    • 9.3.3. Analysis by Patent Application Year
    • 9.3.4. Analysis by Patent Jurisdiction
    • 9.3.5. Analysis by CPC Symbols
    • 9.3.6. Analysis by Type of Applicant
    • 9.3.7. Leading Industry Players: Analysis by Number of Patents
    • 9.3.8. Leading Individual Assignees: Analysis by Number of Patents

10. GRANTS ANALYSIS

  • 10.1. Analysis Methodology and Key Parameters
  • 10.2. Cell-based Assay: Grant Analysis
    • 10.2.1. Analysis by Year of Grant Award
    • 10.2.2. Analysis by Amount Awarded
    • 10.2.3. Analysis by Support Period
    • 10.2.4. Analysis by Type of Funding Institute Center and Support Period
    • 10.2.5. Analysis by Grant Application
    • 10.2.6. Analysis by Purpose of Grant Award
    • 10.2.7. Analysis by Type of Funding Institute Center
    • 10.2.8. Most Popular NIH Departments

11. MARKET IMPACT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Market Drivers
  • 11.3. Market Restraints
  • 11.4. Market Opportunities
  • 11.5. Market Challenges
  • 11.6. Conclusion

12. INDIA CELL-BASED ASSAY MARKET

  • 12.1. Chapter Overview
  • 12.2. Key Assumptions and Methodology
  • 12.3. India Cell-based Assay Market, Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
  • 12.4. Roots Analysis Perspective on Market Growth
  • 12.5 Scenario Analysis
    • 12.5.1. Conservative Scenario
    • 12.5.2. Optimistic Scenario
  • 12.6. Key Market Segmentations

13. INDIA CELL-BASED ASSAY MARKET, BY TYPE OF PRODUCT

  • 13.1. Chapter Overview
  • 13.2. Key Assumptions and Methodology
  • 13.3. India Cell-based Assay Market: Distribution by Type of ProductSi
    • 13.3.1. India Cell-based Assay Market for Consumables: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
    • 13.3.2. India Cell-based Assay Market for Instruments: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
    • 13.3.3. India Cell-based Assay Market for Software: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
  • 13.4. Data Triangulation and Validation

14. INDIA CELL-BASED ASSAY MARKET, BY TYPE OF ASSAY

  • 14.1. Chapter Overview
  • 14.2. Key Assumptions and Methodology
  • 14.3. India Cell-based Assay Market: Distribution by Type of Assay
    • 14.3.1. India Cell-based Assay Market for Cell Viability: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
    • 14.3.2. India Cell-based Assay Market for Cell Proliferation: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
    • 14.3.3. India Cell-based Assay Market for Cytotoxicity: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
    • 14.3.4. India Cell-based Assay Market for Cell Death: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
    • 14.3.5. India Cell-based Assay Market for Others: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
  • 14.4. Data Triangulation and Validation

15. INDIA CELL-BASED ASSAY MARKET, BY TECHNOLOGY

  • 15.1. Chapter Overview
  • 15.2. Key Assumptions and Methodology
  • 15.3. India Cell-based Assay Market: Distribution by Technology
    • 15.3.1. India Cell-based Assay Market for High-Throughput Screening: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
    • 15.3.2. India Cell-based Assay Market for High-Content Screening: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
    • 15.3.3. India Cell-based Assay Market for Flow Cytometry: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
    • 15.3.4. India Cell-based Assay Market for Label-Free Detection: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
  • 15.4. Data Triangulation and Validation

16. INDIA CELL-BASED ASSAY MARKET, BY APPLICATION

  • 16.1. Chapter Overview
  • 16.2. Key Assumptions and Methodology
  • 16.3. India Cell-based Assay Market: Distribution by Application
    • 16.3.1. India Cell-based Assay Market for Drug Discovery: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
    • 16.3.2. India Cell-based Assay Market for Research: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
    • 16.3.3. India Cell-based Assay Market for ADME / Toxicity Studies: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
    • 16.3.4. India Cell-based Assay Market for Others: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
  • 16.4. Data Triangulation and Validation

17. INDIA CELL-BASED ASSAY MARKET, BY END-USER

  • 17.1. Chapter Overview
  • 17.2. Key Assumptions and Methodology
  • 17.3. India Cell-based Assay Market: Distribution by End-user
    • 17.3.1. India Cell-based Assay Market for Pharmaceutical & Biotechnology Companies: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
    • 17.3.2. India Cell-based Assay Market for Contract Research Organizations: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
    • 17.3.3. India Cell-based Assay Market for Academic / Research Institutions: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
    • 17.3.4. India Cell-based Assay Market for Government Organizations: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
  • 17.4. Data Triangulation and Validation

18. CONCLUDING REMARKS

19. APPENDIX I: TABULATED DATA

20. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS